CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells
- 7 July 2005
- journal article
- review article
- Published by Elsevier
- Vol. 5 (1) , 40-45
- https://doi.org/10.1016/j.autrev.2005.06.001
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3Immunity, 2005
- Tolerance, not immunity, crucially depends on IL-2Nature Reviews Immunology, 2004
- Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα TherapyThe Journal of Experimental Medicine, 2004
- CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple SclerosisThe Journal of Experimental Medicine, 2004
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T CellsThe Journal of Experimental Medicine, 2002
- Origin of regulatory T cells with known specificity for antigenNature Immunology, 2002
- The enemy within: keeping self-reactive T cells at bay in the peripheryNature Reviews Immunology, 2002